期刊
INTERNATIONAL JOURNAL OF PHARMACEUTICS
卷 280, 期 1-2, 页码 47-55出版社
ELSEVIER
DOI: 10.1016/j.ijpharm.2004.04.019
关键词
pharmaceutical profiling; physicochemical characterizations; solubility; pK(a); log P; IAM partitioning chromatography
资金
- NINDS NIH HHS [2R15NS36393-03A1] Funding Source: Medline
Pharmaceutical profiling studies were conducted on a novel prototype gamma-secretase inhibitor, to determine the potential of its oral absorption. Such compounds can be of use in the treatment of Alzheimer's disease (AD). The studies included determination of solubility, dissociation constant (pK(a)), octanol/water partition coefficient (log P) and the capacity factor (k'(IAM)) on immobilized artificial membrane (IAM) chromatographic columns. The compound is very slightly solubility in water (120 +/- 50 mug/mL) but the solubility increased considerably in basic medium (270 +/- 60 mug/mL). The compound exhibited pK(a) of (10.36 +/- 0.11); and log P of (3.36 +/- 0.16) determined by shake-flask method and (3.31 +/- 0.01) determined by high performance liquid chromatography (HPLC). The experimentally determined log P values correlated well with the calculated one of 3.44. The observed log k'(IAM) value of (2.79 +/- 0.04) indicates that the compound can reasonably be expected to have high membrane permeability, and therefore, good absorption profile if taken orally. This conclusion is also supported by other parameters determined. (C) 2004 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据